As Wright Medical's success suggests, the key for mid-tier companies lies not so much in devising innovative sales and marketing programs for these new customers, but in product planning and portfolio design, crafting the right product line for a more cost-conscious customer, while tapping into those technologically innovative opportunities that still exist.
by David Cassak
Three years ago, orthopedic implant manufacturer Kirschner MedicalCorp. seemed an unlikely candidate for a takeover battle. With revenues of around...
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy
Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.
In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.
